(secondQuint)Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection.

 This study is a randomized, double-blind, placebo-controlled clinical trial of GEN-003 in subjects who have received previous doses of GEN-003 in the GEN-003-003 clinical trial.

 Eligible subjects will be randomized in a 1:1 ratio to receive 1 intramuscular (IM) dose (the maintenance dose) of GEN-003 or placebo.

 Subjects will use a daily electronic reporting tool for reporting the presence or absence of genital herpes lesions, and severity of genital herpes symptoms.

.

 Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection@highlight

The main purpose of this clinical study is to see if a maintenance dose of GEN-003 reduces the number of days that subjects have a genital herpes recurrence.

 The second purpose of the study is to evaluate the safety and tolerablility of a maintenance dose of GEN-003.

